PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma
Authors:
Open Access
- 30 September 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (44) , 72131-72147
Abstract
PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinomaKeywords
This publication has 43 references indexed in Scilit:
- PRMT5 modulates the metabolic response to fasting signalsProceedings of the National Academy of Sciences, 2013
- Melanoma prone families withCDK4germline mutation: phenotypic profile and associations withMC1RvariantsJournal of Medical Genetics, 2013
- Arginine methylation controls growth regulation by E2F‐1The EMBO Journal, 2012
- The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well‐differentiated and dedifferentiated liposarcoma oncogenesis. An analysis of 104 tumorsGenes, Chromosomes and Cancer, 2011
- PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB proteinOncogene, 2011
- Arginine Methylation by PRMT5 at a Naturally Occurring Mutation Site Is Critical for Liver Metabolic Regulation by Small Heterodimer PartnerMolecular and Cellular Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 MethyltransferaseCancer Cell, 2010
- Proliferative Suppression by CDK4/6 Inhibition: Complex Function of the Retinoblastoma Pathway in Liver Tissue and Hepatoma CellsGastroenterology, 2010
- Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK “Inhibitors”Molecular and Cellular Biology, 2006